Important information

Name

CD265 Antibody

Size

0.1ml

Catalog number

bs-2695R

Price

263 €

Extended information

Modification(s)

None

Gene ID number

8792

Target Antigen

CD265

Swiss Prot

Q9Y6Q6

French translation

anticorps

Also known as

CD265 PAb

Immunogen range

60-110/616

Concentration

1ug per 1ul

Conjugation

Unconjugated

Subcellular location

Extracellular

Cross reactivity

Human, Mouse, Rat

Category

Primary Antibodies

Modification site(s)

Unmodified antibody

Clonality

Polyclonal antibody

Clone number

Polyclonal antibody

Tested Applications

WB, IHC-P, IF(IHC-P)

Long name

CD265 Primary Polyclonal Antibody

Purification method

This antibody was purified via Protein A.

Specificity

This is a highly specific antibody against CD265.

Recommended dilutions

WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)

Cross reactive species details

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

Source

This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CD265

Storage conditions

Keep the antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for up to 1 year.

Properties

If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the target antigen

Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis. Involved in the regulation of interactions between T-cells and dendritic cells.

Synonym names

FEO; OFE; ODFR; OSTS; PDB2; RANK; CD265; OPTB7; TRANCER; LOH18CR1; Tumor necrosis factor receptor superfamily member 11A; Osteoclast differentiation factor receptor; Receptor activator of NF-KB; TNFRSF11A